<International Circulation >: There are many interesting sessions here at the AHA 2010 Scientific Sessions.  Can you highlight what you have found to be most interesting?

　《国际循环》：Sacco博士，在美国心脏学会2010年科学年会上有许多有趣的研讨，您可以突出讲一下您觉得的最有趣的话题吗？
　　Dr Sacco: Well， there are many late breaking clinical trials that are being shown at Sessions 2010.  Many of them focusing on different aspects of cardiovascular disease， including， new treatments for atrial fibrillation， new direct thrombin inhibitors and factor Xa inhibitors.  There are reports from large clinical trials for heart failure including some drugs that are being tested to improve heart failure outcomes.  There is a late breaking report from an early trial showing the safety of a new drug to raise HDL among patients with coronary heart disease.  There are reports of new findings on the benefits of stem cells in heart failure and also the report of the CLOSURE trial showing the lack of efficacy for closure of a patent foramen ovale among patients with cryptogenic stroke or TIA.  The meeting is packed full of great new information on the management， prevention and treatments for cardiovascular diseases and stroke.

　Sacco博士：在2010年年会上公布了很多最新的突破性临床试验。他们中的许多侧重于心血管疾病的所有不同的方面 - 包括直接凝血酶抑制剂或Xa因子抑制剂的房颤新疗法。有心衰的新方法，包括有一些药物证明可以改善心衰。有些关于干细胞研究的新进展以及心血管疾病和中风治疗、生理与预防的新信息。